SCHEMBL15511713

SCHEMBL15511713

COc1ccc(CC(Cc2ccc(-c3ccc(C(F)(F)F)cn3)cc2)S(N)(=O)=O)c(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 2/20 0.43
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ ITGB1 P05556 1/20 0.39
▸ ITGA4 P13612 1/20 0.39
▸ TP53 P04637 1/20 0.37
▸ TPH1 P17752 1/20 0.37
▸ PPARD Q03181 3/20 0.36
▸ PPARA Q07869 1/20 0.36
▸ IDO1 P14902 1/20 0.36
▸ TDO2 P48775 1/20 0.36
▸ ALOX5AP P20292 1/20 0.36
▸ FEN1 P39748 1/20 0.36
▸ GAA P10253 2/20 0.35
▸ SCN9A Q15858 1/20 0.35
▸ CASP3 P42574 1/20 0.35
▸ SENP8 Q96LD8 1/20 0.35
▸ SENP7 Q9BQF6 1/20 0.35
▸ SENP6 Q9GZR1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15511711 0.84 KIF11 (0.43) KIF11MEN1KMT2ATP53PPARD
SCHEMBL12494022 0.78 GAA (0.40) KIF11MEN1KMT2ATP53PPARD
SCHEMBL15511710 0.78 TP53 (0.45) KIF11MEN1KMT2ATP53CASP3
SCHEMBL30739004 0.71 RXFP1 (0.53) KIF11MEN1KMT2AIDO1TDO2
SCHEMBL913930 0.71 RXFP1 (0.53) KIF11MEN1KMT2AIDO1TDO2
SCHEMBL12525161 0.71 KIF11 (0.52) KIF11ITGB1ITGA4PPARDPPARA
SCHEMBL28970346 0.71 GAA (0.50) TP53GAA
SCHEMBL1416898 0.68 CYP1A1 (0.47) MEN1KMT2AIDO1TDO2ALOX5AP
SCHEMBL28970341 0.68 GAA (0.47) MEN1KMT2ATP53GAA
SCHEMBL22119480 0.68 POLB (0.62) IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846666-B2 Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof SANOFI (FR) 2014-09-30 — — US disclosed
US-20140066437-A1 OXATHIAZINE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL OR HETEROMETHYLENE GROUPS, METHOD FOR PRODUCING THEM, THEIR USE AS MEDICINE AND DRUG CONTAINING SAID DERIVATIVES AND THE USE THEREOF SANOFI (FR) 2014-03-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140066437-A1 OXATHIAZINE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL OR HETEROMETHYLENE GROUPS, METHOD FOR PRODUCING THEM, THEIR USE AS MEDICINE AND DRUG CONTAINING SAID DERIVATIVES AND THE USE THEREOF SLC5A2, SLC5A1, CYP11B2 KIF11 4470/4885MEN1 1337/4885KMT2A 2312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback